First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 836.25 INR 0.63% Market Closed
Updated: May 31, 2024

Glenmark Life Sciences Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Note Receivable Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Note Receivable
₹3.7B
CAGR 3-Years
9%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Note Receivable
₹4.8B
CAGR 3-Years
109%
CAGR 5-Years
58%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Note Receivable
₹21.4B
CAGR 3-Years
-14%
CAGR 5-Years
-16%
CAGR 10-Years
8%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Note Receivable
₹1.2B
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
-13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Note Receivable
₹1.1B
CAGR 3-Years
10%
CAGR 5-Years
0%
CAGR 10-Years
2%

See Also